Literature DB >> 8334572

CSF shunt infections: a fifteen-year experience with emphasis on management and outcome.

I Morissette1, M Gourdeau, J Francoeur.   

Abstract

A retrospective study of patients with cerebrospinal fluid shunt infections was undertaken from 1975 to 1989 in a university hospital. The data were analyzed with emphasis on the choice of treatment and outcome. There were 44 infectious episodes in 38 patients for an overall rate of 2.6%, including 30 ventriculoperitoneal, 11 ventriculoatrial and 3 lumboperitoneal shunts. The most frequently isolated pathogens were staphylococci in 61% of the cases followed by gram-negative bacilli in 25%. Different modalities of treatment were used: support (2), intravenous antibiotics alone (6), intravenous antibiotics and shunt revision (3), intravenous antibiotics and shunt removal with or without prior externalization of the distal end (33: 13 + 20). The cure rate was 94% (31/33) with this last modality of treatment. Only 3 patients received intraventricular antibiotics. All deaths occurred in patients treated with support only (2) or with antibiotics alone (1). Four of the six recurrent episodes occurred in patients treated with antibiotics alone (2) or with a shunt revision (2). We conclude that carefully chosen intravenous antibiotics combined with shunt removal preceded or not by externalization of the distal end as an alternative therapy to repeated ventricular taps or insertion of an external ventricular drainage device is an appropriate therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334572     DOI: 10.1017/s0317167100047661

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  10 in total

1.  Few Patient, Treatment, and Diagnostic or Microbiological Factors, Except Complications and Intermittent Negative Cerebrospinal Fluid (CSF) Cultures During First CSF Shunt Infection, Are Associated With Reinfection.

Authors:  Tamara D Simon; Nicole Mayer-Hamblett; Kathryn B Whitlock; Marcie Langley; John R W Kestle; Jay Riva-Cambrin; Margaret Rosenfeld; Emily A Thorell
Journal:  J Pediatric Infect Dis Soc       Date:  2013-08-26       Impact factor: 3.164

Review 2.  Linezolid treatment of ventriculoperitoneal shunt infection without implant removal.

Authors:  P Castro; A Soriano; C Escrich; G Villalba; M Sarasa; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

3.  Timing of ventriculoperitoneal shunt insertion following spina bifida closure in Kenya.

Authors:  Franklin C Margaron; Dan Poenaru; Richard Bransford; A Leland Albright
Journal:  Childs Nerv Syst       Date:  2010-04-27       Impact factor: 1.475

4.  Cerebrospinal Fluid Shunt Infection: Emerging Paradigms in Pathogenesis that Affect Prevention and Treatment.

Authors:  Tamara D Simon; Joshua K Schaffzin; Charles B Stevenson; Kathryn Willebrand; Matthew Parsek; Lucas R Hoffman
Journal:  J Pediatr       Date:  2018-12-06       Impact factor: 4.406

5.  Reinfection following initial cerebrospinal fluid shunt infection.

Authors:  Tamara D Simon; Matthew Hall; J Michael Dean; John R W Kestle; Jay Riva-Cambrin
Journal:  J Neurosurg Pediatr       Date:  2010-09       Impact factor: 2.375

6.  2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Authors:  Allan R Tunkel; Rodrigo Hasbun; Adarsh Bhimraj; Karin Byers; Sheldon L Kaplan; W Michael Scheld; Diederik van de Beek; Thomas P Bleck; Hugh J L Garton; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

7.  Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2018-02-02       Impact factor: 2.375

8.  Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy Gove; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatr       Date:  2016-09-28       Impact factor: 4.406

9.  Sterile surgical technique for shunt placement reduces the shunt infection rate in children: preliminary analysis of a prospective protocol in 115 consecutive procedures.

Authors:  Benoit J M Pirotte; Alphonse Lubansu; Michael Bruneau; Chakir Loqa; Nathalie Van Cutsem; Jacques Brotchi
Journal:  Childs Nerv Syst       Date:  2007-08-18       Impact factor: 1.475

10.  Evaluation of microbial bacterial and fungal diversity in cerebrospinal fluid shunt infection.

Authors:  Tamara D Simon; Christopher E Pope; Samuel R Browd; Jeffrey G Ojemann; Jay Riva-Cambrin; Nicole Mayer-Hamblett; Margaret Rosenfeld; Danielle M Zerr; Lucas Hoffman
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.